Search clinical trials for: Maurora® Sirolimus Eluting Stent System

Total 354 results

Beijing Tiantan Hospital
Alain Medical (Beijing) Co., Ltd.

Recruiting

Evaluating the Safety and Efficacy of the Maurora® DES in ICAS (Maurora ICAS)

Intracranial Arteriosclerosis | Stroke (CVA) or TIA

China
Shigeru Saito
NPO International TRI Network

Terminated

Nobori And Uncoated Stent In Coronary Attack

Acute Myocardial Infarction

Japan
Hyogo College of Medicine

Withdrawn

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (ASSESS)

Coronary Artery Disease | Atherosclerosis

Japan
Aarhus University Hospital Skejby
Medtronic Cardiovascular; Biosensors International

Completed

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® (SO VI)

Coronary Artery Disease | Angina Pectoris

Denmark
Deutsches Herzzentrum Muenchen

Completed

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography (TEST-6-OCT)

Coronary Heart Disease

Germany
Odense University Hospital

Unknown

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent (SORT OUT VII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Maasstad Hospital

Unknown

Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent (COMPARE-II)

Coronary Artery Disease

Netherlands, Spain, Switzerland, Greece
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)

Coronary Artery Disease

Japan
Masaryk University

Unknown

Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction (ROBUST)

Coronary Heart Disease | Percutaneous Coronary Intervention

Czech Republic
Hospital Universitari Vall d'Hebron Research Institute
B.Braun Surgical SA

Completed

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Coronary Artery Disease

Spain
Nanjing First Hospital, Nanjing Medical University

Withdrawn

Coronary Bifurcation Lesions Treated With Biguard Stent System (BIGUARD)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Yonsei University

Unknown

Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents (CTO)

Coronary Artery Disease

Korea, Republic of
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
OrbusNeich
CCRF Inc., Beijing, China; OrbusNeich Medical (Shenzhen), Co. Ltd.

Completed

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions (RECOVERY)

Coronary Arteriosclerosis

China
Beijing AmsinoMed Medical Device Co., Ltd

Unknown

To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

Myocardial Ischemia | Coronary Disease | Acute Coronary Syndrome | Ischemic Heart Disease

China
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Medfavour (Beijing) Medical Co., Ltd
Chinese Academy of Medical Sciences, Fuwai Hospital; Division of Biometrics...

Unknown

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Coronary Artery Diseases

China
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Meril Life Sciences Pvt. Ltd.
Lifecare Institute of Medical Sciences and Research Ahmedabad Gujarat India

Completed

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions (meriT-1)

Coronary Artery Disease

India
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions (LONG-DES-V)

Coronary Artery Disease

Korea, Republic of
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Deutsches Herzzentrum Muenchen

Unknown

Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography (PPS/PFS-OCT)

Coronary Heart Disease

Germany
Instituto Nacional de Cardiologia Ignacio Chavez

Recruiting

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk (ZEVS-HBR)

Coronary Artery Disease | Percutaneous Coronary Intervention | High Bleeding Risk

Mexico
CCRF Consulting Co., Ltd.

Unknown

ProStent Coronary Drug-Eluting Stent (Prostent)

Coronary Disease

China
Genoss Co., Ltd.

Recruiting

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

Coronary Artery Disease | Drug-eluting Stent

Korea, Republic of
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
University of Freiburg

Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents (EVERBIOII)

Coronary Artery Disease

Switzerland
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Yonsei University

Completed

A New Strategy Regarding Discontinuation of Dual Antiplatelet

Coronary Artery Disease

Korea, Republic of
Catholic University of the Sacred Heart

Completed

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (Z-SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Cook Group Incorporated

Completed

Zilver® PTX® in China

Peripheral Artery Disease

China
Universitaire Ziekenhuizen KU Leuven

Completed

STACCATO: Stent sTrut Apposition and Coverage in Coronary ArTeries: an Optical Coherence Tomography (OCT) Study (STACCATO)

Coronary Artery Disease

Belgium
Cook Research Incorporated

Completed

Zilver® PTX® V Clinical Study

Peripheral Arterial Disease

United States
Xijing Hospital
Air Force Military Medical University, China; Shanghai MicroPort Medical (Group)... and other collaborators

Unknown

Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions (FIREMAN)

Coronary Disease

China
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions (ISAR-CABG)

Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Germany
Phillip Freeman
Odense University Hospital; Aarhus University Hospital; Biosensors International and other collaborators

Active, not recruiting

Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent (SORTOUTXI)

Coronary Artery Disease

Denmark
Medical University of Vienna

Completed

Late Acquired Malaposition and Different Polymers

Late Acquired Stent Malaposition

Austria
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) (PROTECT)

Ischemic Heart Disease

Netherlands
Shanghai Jiao Tong University School of Medicine

Unknown

Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease (FESTA)

Coronary Artery Disease

China
Odense University Hospital

Completed

Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation (OCTACS)

Myocardial Infarction | Coronary Artery Disease
Broncus Technologies

Unknown

EASE Trial: Exhale Airway Stents for Emphysema (EASE)

Emphysema

United States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
Thorax Centrum Twente

Unknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCHPEERS)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
R&D Cardiologie
Cordis Corporation

Completed

Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium

Search clinical trials for: Maurora® Sirolimus Eluting Stent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations